Skip to main content

Physician Resources

Recently Added |view more

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy (GAIN-BCG) News

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy (GAIN-BCG)

This phase III trial compares the effect of adding gemcitabine to intravesical Bacillus Calmette Guerin (BCG) versus intravesical BCG alone in patients with non-muscle invasive bladder cancer that has come back after a period of improvement (recurrent).

Adaptive Radiation Therapy for Men with Intermediate- or High-Risk Prostate Cancer (DE-CART) News

Adaptive Radiation Therapy for Men with Intermediate- or High-Risk Prostate Cancer (DE-CART)

The goal of this clinical trial is to evaluate if adaptive stereotactic body radiation therapy (SBRT) is a safe and effective way to treat prostate cancer in adults. It will assess the safety profile of adaptive SBRT over time.

Fox Chase Cancer Center Celebrates Innovation, Sustained Growth, and Upward Momentum News

Fox Chase Cancer Center Celebrates Innovation, Sustained Growth, and Upward Momentum

When it comes to cancer, our work can seem insurmountable. But look closer, and it offers enduring hope. Despite the demands — or perhaps because of them — the faculty and staff at Fox Chase Cancer Center steadily rise above to achieve more.

The First NCI-Designated Comprehensive Cancer Center Using 3D Genomics Testing to Diagnose Lymphoma and Sarcoma—a True Game Changer News

The First NCI-Designated Comprehensive Cancer Center Using 3D Genomics Testing to Diagnose Lymphoma and Sarcoma—a True Game Changer

Diagnosing lymphoma and sarcoma can be extraordinarily complex, with more than 70 recognized subtypes of lymphoma and more than 100 distinct types of sarcoma. Many subtypes share similar features yet behave in dramatically different ways ...

Delivering Big Ideas from ASH 2025 News

Delivering Big Ideas from ASH 2025

At Fox Chase Cancer Center and Temple University Hospital, it’s “in the blood” of our residents and Fellows to develop innovative scientific ideas that significantly affect the way blood diseases are diagnosed and treated. Here is the latest from ASH 2025:

Fellowship Training That Goes Where You Go News

Fellowship Training That Goes Where You Go

As Chief Fellow Giuliana Berardi, MD, a third-year Hematology/Oncology Fellow at Fox Chase Cancer Center, reflected on her medical training, she noted the steep learning curve that accompanied each new level of medical training.

Preparing for the Routine and Unforeseen in the Urologic OR News

Preparing for the Routine and Unforeseen in the Urologic OR

From 11 am to 11 pm, Joon Park, MSHI, BSN, RN, CNOR, Fox Chase Cancer Center Perioperative Evening Charge Nurse, manages the surgical staff workflow and patient assignments for the Fox Chase Cancer operating room.

Fox Chase Fellows Shape the World of Cancer Care News

Fox Chase Fellows Shape the World of Cancer Care

Wherever they go, Fox Chase Fellows and residents bring a significant contribution to the world of cancer care, from distinguished JAMA peer reviews to notable advances in the field of neuroendocrine cancer to accolades for research, academy ...

Unconventional and Exceptional: Dr. Lee’s Fox Chase Residency News

Unconventional and Exceptional: Dr. Lee’s Fox Chase Residency

Peter L. Lee, MD, PhD, has two distinct and interesting roles in radiation oncology at the Mass General Brigham Cancer Institute: one as radiation oncologist specializing in GU cancers, and another as a leader tasked to develop the hospital’s ...